All In Biotech

Free tool

FAERS Monitor: Strattera

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 021411 or its brand name (Strattera, Atomoxetine Hydrochloride). Reports on generic versions are filed under their own applications.

Reports

23,874

Serious

9,462

40% of reports

Hospitalization

3,460

Death reported

1,574

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • drug ineffective2,439
  • fatigue1,931
  • nausea1,898
  • vomiting1,522
  • headache1,510
  • dizziness1,430
  • somnolence1,361
  • off label use1,304
  • insomnia1,281
  • depression1,198
  • feeling abnormal1,186
  • abdominal pain upper1,181
  • prescribed overdose1,145
  • anxiety1,056
  • suicidal ideation1,010

Reports by year received

View as table
YearReports
20045,235
20053,700
2006579
2007510
2008415
2009557
2010398
2011414
2012474
2013409
2014534
20154,499
2016808
2017508
2018416
2019441
2020355
2021296
2022366
2023441
2024722
20251,215
2026582

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,030,285 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
prescribed overdoseSignal1,14555.352.257,485
suicidal ideationSignal1,0109.89.27,936
somnolenceSignal1,3616.05.75,667
abdominal pain upperSignal1,1815.14.83,878
depressionSignal1,1984.74.43,457
feeling abnormalSignal1,1864.44.13,107
insomniaSignal1,2814.34.03,209
anxietySignal1,0563.33.11,686
vomitingSignal1,5222.92.71,872
dizzinessSignal1,4302.52.41,350
fatigueSignal1,9312.22.11,289
headacheSignal1,5102.12.0923
nauseaSignal1,8982.12.01,156
drug ineffective2,4391.61.6634
off label use1,3041.31.2101

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.